Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Mirabegron is an agonist of the β3-adrenergic receptor (β3-AR).1 It induces cAMP accumulation in CHO cells expressing the β3-AR but not the β1- or β2-AR (EC50s = 0.0224, >10, and >10 µM, respectively). Mirabegron reduces contraction induced by carbamoylcholine (Item No. 14486) of isolated rat and human bladder strips (EC50s = 5.1 and 0.78 µM, respectively). It decreases the frequency of isovolumetric rhythmic bladder contractions in anesthetized rats when administered at a dose 3 mg/kg. Formulations containing mirabegron have been used in the treatment of overactive bladder.
WARNING This product is not for human or veterinary use.
1. Effect of (R)-